Better Therapeutics, Inc. (BTTX)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
-50.00%
Market Cap 55.00
Revenue (ttm) n/a
Net Income (ttm) -31.57M
Shares Out 54.52M
EPS (ttm) -1.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 8,741
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0010
Beta -43.12
RSI 24.12
Earnings Date Mar 30, 2026

About Better Therapeutics

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company’s clinical development candidates are intended to treat cardiometabolic diseases, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 54
Stock Exchange OTCMKTS
Ticker Symbol BTTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.